Adipokines and gestational diabetes mellitus

Investuigation of predictors of insulin administration in gestational diabetes mellitus based on adipokines

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040250013

Enrollment

100

Registered

2025-04-28

Start date

2025-02-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with gestational diabetes at the Department of Obstetrics and Gynecology, Nagoya City University West Medical Center, between November 2024 and March 2027. 2. Patients planning to give birth at the Department of Obstetrics and Gynecology, Nagoya City University West Medical Center 3. Women aged 20 or older

Exclusion criteria

Exclusion criteria: 1. Patients who have previously undergone self-injection of insulin. 2. Patients who are unable to confirm their own wishes. 3. Patients who the principal investigator decides inappropriate.

Design outcomes

Primary

Measure	Time frame
Comparison of adipokines including high molecular weight adiponectin, leptin, and FABP4, between insulin-treated and non-insulin-treated groups in gestational diabetes mellitus.	—

Secondary

Measure	Time frame
Comparison of clinical test values between groups that have started insulin treatment and those that have not started it in gestational diabetes mellitus. Comparison of inbody measurement values between groups that have started insulin treatment and those that have not started it in gestational diabetes mellitus.	—

Contacts

Public ContactKenro Imaeda

Nagoya City University West Medical Center

k.imaeda.27@west-med.jp+81-52-991-8121

Outcome results